Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients

Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients

Background: Population-based studies have consistently showed an increased incidence of coronary heart disease and cardiac mortality in patients with type 2 diabetes mellitus (T2DM). Tongmai Jiangtang capsules (TJC) are Chinese patent medicines that have been approved in China for the treatment of d...

Full description

Bibliographic Details
Main Authors: Yu Wang, Yilei Guo, Ye Lei, Shuwei Huang, Liping Dou, Chang Li, Buchang Zhao, Wei Fu, Peng Zhou, Haitong Wan, Mingjun Zhao, Jiehong Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pharmacology
Subjects:
tongmai jiangtang capsules
Chinese medicine
type 2 diabetes mellitus
coronary heart disease
randomized controlled trial
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.625785/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.625785/full

Similar Items